Soliris No More Effective Than Placebo At Treating Myasthenia Gravis: Study
The immunosuppressant Soliris is no more effective at combating myasthenia gravis than a placebo, according to new research.
The immunosuppressant Soliris is no more effective at combating myasthenia gravis than a placebo, according to new research.
The CDC warns that vaccine shots may not be enough to prevent the infection that causes many cases of meningitis in patients taking Soliris, and recommends antimicrobial treatment for as…
The CDC has issued new guidelines designed to help prevent surgical site infections.